Some in the industry expected lobbying spending to level out ahead of the midterms and after numerous pandemic relief bills and the initial burst that a new administration provides.
2022 started strong for healthcare transactions with some reports suggesting a record-breaking January. Although deal activity cooled in February and March, transaction pipelines still.